1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Gliptins

Gliptins

61 - 75 of 86 Results
Sort Results:
Article: Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes May 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013
Article: a possible increase in acute pancreatitis risk with gliptins (Januvia, etc) and GLP-1 agonists (Byetta, etc) April 2013
Chart: Drug-Induced Pancreatitis April 2013
Article: how patients with diabetes should manage drug therapy during sick days March 2013
Commentary: Sick Day Management of Diabetes March 2013
Patient Education: How to Manage Sick Days with Diabetes March 2013
PL Voices: Managing Diabetes During Sick Days March 2013
Article: About 25% of your patients over age 65 have type 2 diabetes November 2012
PL Voices: Managing Type 2 Diabetes in Elderly Patients November 2012
Commentary: Combining a GLP-1 Agonist and a DPP-4 Inhibitor for Type 2 Diabetes August 2012
Article: take both a GLP-1 agonist (Byetta, etc) and DPP-4 inhibitor (Januvia, etc) for type 2 diabetes August 2012
Article: more opportunities to help stem the emerging epidemic of type 2 diabetes in kids and teens July 2012
Guideline: Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada July 2012
PL Voices: Management of Type 2 Diabetes in Kids and Teens July 2012